• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Abasaglar (previously Abasria) insulin glargine 2014-09-09 Eli Lilly Regional Operations GmbH
Abilify aripiprazole 2004-06-04 Otsuka Pharmaceutical Europe Ltd
Abilify Maintena aripiprazole 2013-11-15 Otsuka Pharmaceutical Europe Ltd
Ablavar (previously Vasovist) gadofosveset trisodium 2005-10-03 TMC Pharma Services Ltd.
Abraxane paclitaxel 2008-01-11 Celgene Europe Ltd ?
Abseamed epoetin alfa 2007-08-28 Medice Arzneimittel Pütter GmbH & Co. KG
Accofil filgrastim 2014-09-18 Accord Healthcare Ltd
Aclasta zoledronic acid 2005-04-15 Novartis Europharm Limited
Acomplia rimonabant 2006-06-19 sanofi-aventis
Acrescent memantine hydrochloride / donepezil hydrochloride 2013-02-20 H. Lundbeck A/S
Actelsar HCT telmisartan / hydrochlorothiazide 2013-03-13 Actavis Group hf
Actos pioglitazone 2000-10-13 Takeda Pharma A/S
Actraphane insulin human (rDNA) 2002-10-07 Novo Nordisk A/S
Actrapid human insulin(rDNA) 2002-10-07 Novo Nordisk A/S
Adasuve loxapine 2013-02-20 Ferrer Internacional s.a.
Adcetris brentuximab vedotin 2012-10-25 Takeda Pharma A/S
Adcirca (previously Tadalafil Lilly) tadalafil 2008-10-01 Eli Lilly Nederland B.V.
Adempas riociguat 2014-03-27 Bayer Pharma AG
Adenuric febuxostat 2008-04-21 Menarini International Operations Luxembourg S.A. (MIOL)
Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) 2009-10-10 GlaxoSmithKline Biologicals S.A.